Search Login Register

infliximab (Remicade) Summary

3108 relevant articles (651 outcomes, 522 trials/studies) found for this Drug

Description: a chimeric monoclonal antibody to TNFalpha for the treatment of Crohn's disease & rheumatoid arthritis

Also Known As: Remicade; Centocor brand of infliximab; Essex brand of infliximab; MAb cA2; Schering brand of infliximab Show All >>

Key Diseases for which infliximab is Relevant

  1. Crohn Disease (Crohn's Disease) : 218 outcomes 127 studies in 909 results
  2. Rheumatoid Arthritis : 82 outcomes 120 studies in 686 results
  3. Psoriasis (Pustulosis Palmaris et Plantaris) : 70 outcomes 48 studies in 278 results
  4. Ulcerative Colitis : 56 outcomes 38 studies in 206 results
  5. Necrosis : 55 outcomes 29 studies in 320 results
Show All >>

Drugs Related to infliximab

  1. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  2. TNFR-Fc fusion protein (etanercept)
  3. adalimumab (Humira)
  4. Methotrexate (Mexate)
  5. infliximab (Remicade)
  6. Phenobarbital (Luminal)
  7. Azathioprine (Imuran)
  8. Adrenal Cortex Hormones (Corticosteroids)
  9. efalizumab
  10. Antirheumatic Agents (DMARD)
Show All >>

Therapies Related to infliximab

  1. Retreatment
  2. Biological Therapy
  3. Colectomy
  4. Intravenous Infusions
  5. Aftercare (After-Treatment)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2009 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.